# NELARABINE
> **ANDA212605** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2024-01-03
## Drug
- **FDA Application Number:** ANDA212605
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NELARABINE
- **Generic name:** NELARABINE
- **Active ingredients:** NELARABINE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2024-01-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212605)
---
*MORVS · CC0 1.0*